Nuveen Asset Management, LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$17.63 - $21.74 $7.41 Million - $9.13 Million	420,075 Added 102.2%	831,099 $16.4 Million
Q4 2023 Feb 14, 2024	SELL	$14.37 - $19.07 $2.2 Million - $2.92 Million	-152,902 Reduced 27.11%	411,024 $7.21 Million
Q3 2023 Nov 14, 2023	BUY	$13.62 - $20.2 $6.13 Million - $9.09 Million	450,181 Added 395.78%	563,926 $9.8 Million
Q1 2023 May 15, 2023	SELL	$10.7 - $15.79 $434,131 - $640,647	-40,573 Reduced 26.29%	113,745 $1.22 Million
Q4 2022 Feb 14, 2023	BUY	$11.42 - $17.05 $581,632 - $868,373	50,931 Added 49.26%	154,318 $2.31 Million
Q3 2022 Nov 14, 2022	SELL	$9.76 - $13.41 $46,525 - $63,925	-4,767 Reduced 4.41%	103,387 $1.33 Million
Q2 2022 Aug 15, 2022	BUY	$7.6 - $11.41 $107,737 - $161,748	14,176 Added 15.08%	108,154 $1.05 Million
Q1 2022 May 16, 2022	SELL	$9.3 - $12.37 $123,978 - $164,904	-13,331 Reduced 12.42%	93,978 $966,000
Q4 2021 Feb 14, 2022	BUY	$10.39 - $15.15 $46,682 - $68,068	4,493 Added 4.37%	107,309 $1.26 Million
Q3 2021 Nov 12, 2021	SELL	$11.39 - $16.23 $7,631 - $10,874	-670 Reduced 0.65%	102,816 $1.25 Million
Q2 2021 Aug 16, 2021	BUY	$13.22 - $19.09 $152,598 - $220,355	11,543 Added 12.55%	103,486 $1.44 Million
Q1 2021 May 17, 2021	SELL	$16.68 - $23.97 $5.62 Million - $8.08 Million	-337,060 Reduced 78.57%	91,943 $1.7 Million
Q4 2020 Feb 16, 2021	SELL	$14.8 - $21.15 $231,264 - $330,489	-15,626 Reduced 3.51%	429,003 $7.58 Million
Q3 2020 Nov 16, 2020	BUY	$15.21 - $25.53 $1.76 Million - $2.95 Million	115,527 Added 35.1%	444,629 $6.81 Million
Q2 2020 Aug 14, 2020	BUY	$15.08 - $26.0 $948,758 - $1.64 Million	62,915 Added 23.64%	329,102 $8.39 Million
Q1 2020 May 14, 2020	BUY	$11.0 - $19.76 $2.52 Million - $4.53 Million	229,217 Added 620.01%	266,187 $4.12 Million
Q4 2019 Feb 14, 2020	SELL	$5.24 - $12.96 $19,754 - $48,859	-3,770 Reduced 9.25%	36,970 $409,000
Q3 2019 Nov 14, 2019	BUY	$8.15 - $15.88 $18,345 - $35,745	2,251 Added 5.85%	40,740 $347,000
Q2 2019 Aug 15, 2019	BUY	$13.2 - $20.39 $508,054 - $784,790	38,489 New	38,489 $521,000

Others Institutions Holding KNSA

# of Institutions

Shares Held

1.95M

Call Options Held

Put Options Held

Pictet Asset Management Sa Geneva 73, V8

1.52M
Shares

$33.1 Million
0.03% of portfolio
Spearhead Capital Advisors, LLC Wellington, FL

203K
Shares

$4.42 Million
2.82% of portfolio
Harbor Capital Advisors, Inc.

97.5K
Shares

$2.13 Million
0.11% of portfolio
Putnam Investments LLC Boston, MA

39.5K
Shares

$860,794
0.0% of portfolio
Birchview Capital, LP Burlington, VT

30K
Shares

$654,000
0.69% of portfolio

View Full List

About Kiniksa Pharmaceuticals, Ltd.

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $751M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

More about KNSA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account